ExamFinch.com My Study

Study guide

9.2 Spina Bifida & Myelomeningocele Management

Practice this exam

ABPMR Physical Medicine and Rehabilitation Board Exam Study Guide Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Introduction & Exam Overview

1.1 ABPMR Part I Exam Overview & Format 1.2 Board Review Strategy & Content Blueprint Breakdown

2 Chapter 2: Musculoskeletal Medicine

2.1 Shoulder & Upper Extremity Diagnostics 2.2 Knee, Hip & Lower Extremity Conditions 2.3 Spine Pathology, Radiculopathy & Myelopathy 2.4 Inflammatory Arthritis, Tendinopathies & Concussion 2.5 Bone Health, Osteoporosis & Metabolic Bone Disease 2.6 Thoracic Outlet Syndrome & Peripheral Nerve Entrapment 2.7 Fracture Rehabilitation & Immobilization Complications 2.8 Overuse Tendinopathies & Regenerative Medicine 2.9 Gait Analysis & Abnormal Gait Patterns

3 Chapter 3: Spinal Cord Injury Rehabilitation

3.1 ASIA Examination & Impairment Scale 3.2 Spinal Cord Injury Syndromes 3.3 Autonomic Dysreflexia & Acute Complications 3.4 Neurogenic Bladder, Bowel & Secondary Complications

4 Chapter 4: Stroke & Neuromuscular Rehabilitation

4.1 Stroke Vascular Syndromes & Acute Assessment 4.2 Stroke Motor Recovery & Hemiplegic Complications 4.3 Spasticity Assessment & Multimodal Management 4.4 ALS, GBS, CIDP & Neuromuscular Disease Rehab 4.5 Multiple Sclerosis & Demyelinating Disease Rehabilitation 4.6 Parkinsonism, Movement Disorders & Functional Neurologic Disorder

5 Chapter 5: Electrodiagnostics (EMG/NCS)

5.1 Nerve Conduction Studies Principles & Physics 5.2 Needle Electromyography & MUAP Analysis 5.3 Mononeuropathies & Radiculopathy Patterns 5.4 Neuromuscular Junction Disorders & Myopathies

6 Chapter 6: Traumatic Brain Injury

6.1 TBI Severity Classification, Glasgow Coma Scale, and Pathophysiology 6.2 Rancho Los Amigos Levels of Cognitive Functioning and Disability Rating Scale 6.3 Neurobehavioral Sequelae and Agitation Management 6.4 Concussion Evaluation, Vestibular-Ocular Dysfunction, and Return-to-Play/Work Protocols

7 Chapter 7: Chronic Pain & Interventional Spine

7.1 Fluoroscopic Spine Interventions 7.2 Opioid Stewardship & Controlled Substance Compliance 7.3 Complex Regional Pain Syndrome, Fibromyalgia & Myofascial Pain 7.4 Spinal Cord Stimulation & Intrathecal Therapy

8 Chapter 8: Amputee Rehabilitation & Prosthetics

8.1 Amputation Surgical Levels & Medicare K-Levels 8.2 Socket Designs & Suspension Systems 8.3 Prosthetic Feet & Microprocessor Knee Mechanisms 8.4 Post-Amputation Care, Residual Limb & Phantom Pain

9 Chapter 9: Pediatric Rehabilitation

9.1 Cerebral Palsy Classification & GMFCS 9.2 Spina Bifida & Myelomeningocele Management 9.3 Muscular Dystrophies & Neuromuscular Disease in Children 9.4 Pediatric Brachial Plexopathy & Congenital Disorders

10 Chapter 10: Prosthetics, Orthotics & Assistive Technology

10.1 Lower Limb Orthoses — AFOs & KAFOs 10.2 Spinal & Upper Extremity Orthoses 10.3 Upper Limb Prosthetics — Body-Powered vs Myoelectric 10.4 Wheelchairs, Seating Systems & Pressure Mapping

11 Chapter 11: Medical Rehabilitation & Outcomes

11.1 Dysphagia Assessment & Management 11.2 Neurogenic Bladder & Bowel Management 11.3 Pressure Injuries & Wound Management 11.4 Outcome Measures & Medical Complications 11.5 Cancer Rehabilitation & Oncologic Rehabilitation 11.6 Burns, Endocrine/Metabolic & Medical Complications Rehabilitation

12 Chapter 12: Cardiopulmonary Rehabilitation

12.1 Cardiac Rehabilitation Phases & Metabolic Equivalents 12.2 Pulmonary Rehabilitation & COPD Management

13 Chapter 13: Foundational Rehabilitation Concepts

13.1 Kinesiology, Biomechanics & Functional Anatomy 13.2 Rehabilitation Pharmacology & Medication Management 13.3 Research Methodology, Biostatistics & Evidence-Based Practice 13.4 Nutrition, Metabolism & Energy Expenditure in Rehabilitation 13.5 Diagnostic Procedures: Imaging, MSK Ultrasound, Urodynamics & Neuropsych Assessment

9.2 Spina Bifida & Myelomeningocele Management

Key Takeaways Explain This Topic AI

Myelomeningocele (MMC) functional ambulation is determined primarily by the motor level: Thoracic/L1-L2 are wheelchair-dependent, L3-L4 are household ambulators (with KAFOs/RGOs), L5 are community ambulators (with AFOs), and S1-S3 are community ambulators without orthoses.

Primary prevention of neural tube defects requires maternal folic acid supplementation: 400 mcg daily for standard risk and 4 mg (4,000 mcg) daily starting 1 month prior to conception for high-risk women.

Hydrocephalus is present in >80-90% of MMC patients, strongly associated with Chiari II malformation; VP shunt failure presents with signs of raised ICP (sunsetting eyes, bulging fontanelle in infants; morning headache, strabismus, academic decline in older children).

Neurogenic bladder management must begin in early infancy with Clean Intermittent Catheterization (CIC) and anticholinergics to prevent high storage pressures (>40 cm H2O), vesicoureteral reflux, hydronephrosis, and renal failure.

Neurogenic bowel programs combine timed evacuation, laxatives, retrograde enemas, or surgical options like the Malone Antegrade Continence Enema (MACE) to achieve bowel continence.

Last updated: July 2026

Etiology and Prevention of Neural Tube Defects

Neural Tube Defects (NTDs) result from failure of primary neurulation, which normally completes by day 28 of gestation (prior to realization of pregnancy).

Spectrum of Spina Bifida

Spina Bifida Occulta : Failure of posterior vertebral arch fusion without cord or meningeal herniation. Often marked by an overlying hair tuft, dermal sinus, or nevus.

Meningocele : Herniation of meninges and CSF through vertebral defect; spinal cord remains within the spinal canal. Neurologic function is typically intact.

Myelomeningocele (MMC) : Open NTD with herniation of meninges and spinal cord elements. Represents the vast majority of clinically significant spina bifida cases.

Folate Supplementation Protocols

Periconceptional maternal folic acid supplementation significantly reduces NTD risk:

Standard Primary Prevention : All women of childbearing age should consume 400 mcg (0.4 mg) of folic acid daily.

High-Risk Prevention : Women with a prior affected child or taking anti-seizure medications (valproic acid, carbamazepine) require 4 mg (4,000 mcg) daily starting 1 month prior to conception through the first trimester.

Maternal screening includes elevated maternal serum alpha-fetoprotein (MSAFP) and fetal ultrasonography. Management includes in utero fetal repair (MOMS trial) or early postnatal closure (<48 hours).

Neurologic Motor Levels and Functional Ambulation Prognosis

The motor level is defined as the lowest spinal cord segment with at least grade 3/5 (antigravity) strength. Functional ambulation and orthotic needs correlate directly with motor level.

Thoracic and High Lumbar (L1-L2) Levels

Motor Function : L1 preserves hip flexion; L2 preserves full hip flexion and adduction. No active knee extension or ankle movement.

Ambulation & Orthotics : Non-ambulatory; wheelchair dependent . Young children may use a parapodium, swivel walker, or Hip-Knee-Ankle-Foot Orthosis (HKAFO) for exercise ambulation, but transition to a manual wheelchair by late childhood. High risk of scoliosis (>90%).

Mid-Lumbar (L3-L4) Levels

Motor Function : L3 level requires quadriceps strength grade ≥3/5 (knee extension). L4 level adds active ankle dorsiflexion (tibialis anterior grade ≥3/5). Hamstrings and gluteals remain weak or absent.

Ambulation & Orthotics : Household or limited community ambulators . Requires Knee-Ankle-Foot Orthoses (KAFOs) or Reciprocating Gait Orthoses (RGOs) with forearm crutches or rolling walker. Demonstrates crouch gait.

Low Lumbar (L5) Level

Motor Function : Active ankle dorsiflexion, extensor hallucis longus, and hamstring strength (grade ≥3/5). Weakness persists in gluteus medius/maximus (grade <3/5) and gastrocnemius.

Ambulation & Orthotics : Community ambulators . Uses Ankle-Foot Orthoses (AFOs) and crutches or canes. Displays a characteristic Trendelenburg gait due to gluteus medius weakness.

Sacral (S1-S3) Levels

Motor Function : S1 level adds active plantarflexion (gastrocnemius grade ≥3/5) and improved gluteus maximus strength. S2-S3 levels preserve intrinsic foot muscles and sphincter tone.

Ambulation & Orthotics : Community ambulators without orthoses (or with minimal foot orthoses/SMOs). Gait is near-normal.

Motor Level Key Preserved Muscle Group Functional Ambulation Status Primary Orthotic & Assistive Device

Thoracic / L1-L2 Hip flexors (L1-L2) Non-ambulatory / Wheelchair dependent Parapodium (exercise); Manual Wheelchair

L3 - L4 Quadriceps (L3), Tibialis Anterior (L4) Household / Limited Community ambulator KAFOs or RGOs with forearm crutches

  • L5 Extensor Hallucis, Hamstrings Community ambulator AFOs (floor reaction) with crutches/canes
  • S1 - S3 Gastrocnemius/Soleus (S1) Community ambulator Foot orthoses / SMOs or no orthoses
  • Hydrocephalus and VP Shunt Malfunction

Hydrocephalus develops in >80-90% of MMC children, secondary to Chiari II Malformation (caudal displacement of cerebellar vermis, brainstem, and 4th ventricle through foramen magnum).

Clinical Presentation of VP Shunt Malfunction

VP shunt failure is a neurosurgical emergency. Symptoms vary by age:

Infants : Bulging anterior fontanelle, rapidly increasing head circumference, sunsetting eyes (downward ocular deviation from midbrain tectum pressure), irritability, vomiting, lethargy.

Older Children : Morning headache, recurrent nausea/vomiting, drop in academic performance, diplopia/strabismus due to abducens nerve (CN VI) palsy , new or worsening spasticity, and gait deterioration.

Emergency Workup : Non-contrast head CT or MRI, shunt series X-rays (skull to abdomen), and urgent neurosurgical revision.

Tethered Cord Syndrome & Latex Allergy Precautions

Tethered Cord Syndrome occurs when scarring at the surgical repair site restricts normal physiological movement of the spinal cord during growth. Clinical presentation includes progressive lower extremity weakness, gait deterioration, new or worsening spasticity, back or leg pain, new foot deformities (cavovarus), and changes in bladder or bowel control. Diagnosis is established by MRI spine showing low-lying conus medullaris (below L2) and thick filum terminale; treatment requires surgical neurosurgical untethering.

Latex Allergy Precautions : Up to 70% of individuals with myelomeningocele develop severe latex hypersensitivity (IgE-mediated Type I reaction) due to repeated early exposure during surgical repairs and urinary catheterizations. Strict universal latex precautions (latex-free gloves, catheters, and medical supplies) must be maintained for all patients with spina bifida from birth.

Neurogenic Bladder and Bowel Management

Denervation of S2-S4 sacral segments produces a neurogenic bladder.

Urologic Management & Renal Preservation

Elevated bladder storage pressure ( leak point pressure >40 cm H2O ) secondary to detrusor-sphincter dyssynergia (DSD) leads to vesicoureteral reflux (VUR) , hydronephrosis, pyelonephritis, and renal scarring.

Clean Intermittent Catheterization (CIC) : Started in early infancy (every 3-4 hours) to maintain low storage pressures.

Anticholinergic Therapy : Oral oxybutynin to reduce detrusor hyperreflexia and improve compliance.

Surveillance : Serial renal ultrasound and urodynamic studies (UDS) performed annually starting in infancy.

Neurogenic Bowel Management

Denervation causes loss of rectosphincteric reflex and anal sphincter tone. Management includes timed evacuation, osmotic laxatives (PEG), suppositories, transanal irrigation, or the Malone Antegrade Continence Enema (MACE) (surgical appendicostomy for daily enema flushing).